Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
about
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular diseaseSystematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian PopulationThe Abdominal Aortic Aneurysm and Intraluminal Thrombus: Current Concepts of Development and TreatmentRegulation of atherogenesis by chemokines and chemokine receptorsStatins, inflammation and deep vein thrombosis: a systematic reviewLong-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic reviewStatins potently reduce the cytokine-mediated IL-6 release in SMC/MNC coculturesAssessment of atherosclerotic plaques in the rabbit abdominal aorta with interleukin-8 monoclonal antibody-targeted ultrasound microbubbles.Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesionsAssociations between statins and COPD: a systematic review.Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin.Impact of macrophage inflammatory protein-1α deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansionHerpes zoster is associated with prior statin use: a population-based case-control study.Simvastatin suppresses breast cancer cell proliferation induced by senescent cellsIL-1β and IL-18: inflammatory markers or mediators of hypertension?Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction.Lack of therapeutic interchangeability of HMG-CoA reductase inhibitors.Association between statin use and uveitis: results from the Pacific Ocular Inflammation studyDry powder formulation of simvastatin.Noncholesterol-lowering effects of statins.Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia.Benefits and risks assessment of simvastatin in familial hypercholesterolaemia.Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.Novel applications of statins for bone regenerationAdipokines, diabetes and atherosclerosis: an inflammatory association.Differential metabolic actions of specific statins: clinical and therapeutic considerationsAngiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment.Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.Statin use and ocular inflammatory disease risk.Statins as first-line therapy for acute coronary syndrome?Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis.Potential therapeutic role of statins in neurological disorders.Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes.Antibiotic and anti-inflammatory therapies for cystic fibrosis.Statin adjunctive therapy shortens the duration of TB treatment in mice.Statins in the first-line therapy of acute coronary syndrome - similar to aspirin?Translocation of bacterial NOD2 agonist and its link with inflammation.Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes.Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression.
P2860
Q25257027-06CE14DC-DA40-488A-BEBE-FD9E96EE8EB1Q26774109-29D7C07E-89AA-41ED-8359-6493ECB44B45Q26776131-E9A3254A-C46E-40E4-8275-3C23094FE813Q27003124-979522BF-BA05-43E3-8189-D83657E9B549Q27027545-DB1943DF-F342-4865-AD23-5ADEA66155B8Q28755180-4EB2A89C-D1EA-4AE8-A688-9BA17CBE4833Q30318772-7CC28E38-51D5-4098-A1D4-9C87FBCA85E2Q30457409-9F2161CE-858A-4DC3-BEC6-F0708B04F975Q30488574-12E11C4F-5078-4C2B-AA18-F5493F0CCEA8Q33481269-3443F8DE-A6E5-4488-8959-A0DEDCA9567EQ33633640-FEFE817C-A409-416B-BBC4-5E891D1F94CEQ34168259-0B983AF7-6E22-4144-A3C4-E2AE94D512A2Q34400948-E018C9DF-BE12-4DDF-A533-FC4B815F2BEEQ34504829-B2827D12-B735-4E41-A91B-5388316CA401Q34914125-5BA06EC6-8893-49DE-9C19-1EF9861535CAQ34991508-B79F10CD-391A-4E05-B76D-EDEF9B69DBB9Q35009456-49923AE4-56A5-42F5-B199-E6DB88DA7FE2Q35181364-AC3FB918-1E35-49C8-ABB6-91415655817AQ35269057-A85C01E7-C31C-4EEB-AD15-D20422AE141EQ35551180-8D7E991C-26CD-48AB-AA14-EFA3834D949BQ36040720-E7C9B3D0-77FE-42F1-8ECF-4E07E59EAD99Q36081978-E4891FCE-6DBC-46DA-BD7C-350AE03B9EDBQ36088110-73D466EC-E050-440E-A98B-A31CE79A224BQ36240108-5AE4E4F3-AE09-46B5-9B97-BACA77DFDF91Q36241112-32D387EC-0A69-4567-8040-635768D2B10EQ36406951-539EC781-9A93-482F-9CF7-ED2FFA35E6BCQ36548151-2A1EE867-0928-4267-A98E-A93B0F51B04CQ36577189-BF23DDE2-264D-4FBC-A4FA-14D2685B507CQ36674896-4CF9A604-66EA-4EC6-8B21-12BC4788EEEFQ36707183-610C0A72-E7C3-4E8B-882C-063A746D90E9Q36768488-CBCE0EAE-4DFA-4A7E-A096-517450E13B17Q36843060-BEBEDBC2-B81C-49E1-88EB-98A7F92F7967Q37154822-7817F673-0543-40AA-9E5D-0E51B57B1331Q37181767-6C39C5BA-D478-4B9E-A83A-CD0082B5CEB3Q37201467-34F45EAF-50EE-460A-9C11-B7D3D3CD4AF1Q37223747-79D38B71-EC4A-4501-B2EA-BDE1680F4032Q37276466-F6EDFBFC-B4FE-474E-BF63-3F9BE2C7E882Q37360336-1D18EBA2-0B61-431B-BAFB-61ACDE2C75A4Q37396582-8D7DCDD1-8C71-4B69-A90E-EF66656EFA67Q37397533-EA7B12BF-9425-497A-A610-E83672B5AEF9
P2860
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Simvastatin reduces expression ...... hypercholesterolemic patients.
@en
Simvastatin reduces expression ...... hypercholesterolemic patients.
@nl
type
label
Simvastatin reduces expression ...... hypercholesterolemic patients.
@en
Simvastatin reduces expression ...... hypercholesterolemic patients.
@nl
prefLabel
Simvastatin reduces expression ...... hypercholesterolemic patients.
@en
Simvastatin reduces expression ...... hypercholesterolemic patients.
@nl
P2093
P921
P1476
Simvastatin reduces expression ...... hypercholesterolemic patients
@en
P2093
Abdolreza Rezaie-Majd
Ahmad Kashanipour
Erich Minar
Mehrdad Baghestanian
Michael R Müller
Peter Husslein
Robert A Bucek
Thomas Maca
P304
P356
10.1161/01.ATV.0000022694.16328.CC
P407
P50
P577
2002-07-01T00:00:00Z